.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Teva
Chinese Patent Office
QuintilesIMS
Deloitte
Baxter
Argus Health
Novartis
Cipla
Healthtrust

Generated: December 12, 2017

DrugPatentWatch Database Preview

Parke Davis Company Profile

« Back to Dashboard

What is the competitive landscape for PARKE DAVIS, and what generic alternatives to PARKE DAVIS drugs are available?

PARKE DAVIS has one hundred and four approved drugs.

There are two US patents protecting PARKE DAVIS drugs.

Summary for Parke Davis

US Patents:2
Tradenames:77
Ingredients:68
NDAs:104
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Parke DavisTRIPELENNAMINE HYDROCHLORIDEtripelennamine hydrochlorideTABLET;ORAL083625-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Parke DavisMEPERIDINE HYDROCHLORIDEmeperidine hydrochlorideINJECTABLE;INJECTION080364-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Parke DavisEUTHROID-1liotrix (t4;t3)TABLET;ORAL016680-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Parke DavisSULFALARsulfisoxazoleTABLET;ORAL084955-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Parke DavisAMBODRYLbromodiphenhydramine hydrochlorideCAPSULE;ORAL007984-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Parke DavisMETHYLDOPA AND HYDROCHLOROTHIAZIDEhydrochlorothiazide; methyldopaTABLET;ORAL071899-001Nov 23, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Parke DavisPRE-SATEchlorphentermine hydrochlorideTABLET;ORAL014696-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Parke DavisNORLESTRIN 28 1/50ethinyl estradiol; norethindrone acetateTABLET;ORAL-28016723-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Parke DavisPROCANprocainamide hydrochlorideCAPSULE;ORAL087502-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Parke DavisHEPARIN SODIUMheparin sodiumINJECTABLE;INJECTION017346-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Parke Davis

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Parke DavisNEURONTINgabapentinSOLUTION;ORAL021129-001Mar 2, 2000► Subscribe► Subscribe
Parke DavisCHOLYBARcholestyramineBAR, CHEWABLE;ORAL071621-001May 26, 1988► Subscribe► Subscribe
Parke DavisNEURONTINgabapentinSOLUTION;ORAL021129-001Mar 2, 2000► Subscribe► Subscribe
Parke DavisNEURONTINgabapentinSOLUTION;ORAL021129-001Mar 2, 2000► Subscribe► Subscribe
Parke DavisCEREBYXfosphenytoin sodiumINJECTABLE;INJECTION020450-001Aug 5, 1996► Subscribe► Subscribe
Parke DavisFEMPATCHestradiolFILM, EXTENDED RELEASE;TRANSDERMAL020417-001Dec 3, 1996► Subscribe► Subscribe
Parke DavisCEREBYXfosphenytoin sodiumINJECTABLE;INJECTION020450-001Aug 5, 1996► Subscribe► Subscribe
Parke DavisFEMPATCHestradiolFILM, EXTENDED RELEASE;TRANSDERMAL020417-001Dec 3, 1996► Subscribe► Subscribe
Parke DavisCHOLYBARcholestyramineBAR, CHEWABLE;ORAL071739-001May 26, 1988► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for PARKE DAVIS drugs

Drugname Dosage Strength Tradename Submissiondate
nitroglycerinSublingual Tablets0.6 mgNITROSTAT12/29/2011
nitroglycerinSublingual Tablets0.3 mg, 0.4 mg and 0.6 mgNITROSTAT10/19/2005

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
UBS
Fish and Richardson
Deloitte
Moodys
Federal Trade Commission
Julphar
Queensland Health
Johnson and Johnson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot